Species
Filter by Species
Filter by Toxicity Endpoint Type
Filter by Exposure Endpoint Type
Filter by Chemical
Filter by Location
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
DIELDRIN | 178 - 684 | steady state bioconcentration factor for skin, calculated on a wet weight basis; range for 7 doses | Not Reported | Juvenile | 8-16/dose | 0, 0.014, 0.019, 0.052, 0.075, 0.118, 0.177, 0.193 mg/L | TOX-EXP IND - accumulation | 8-34 d | waterborne | Toxicity Factor Datasets |
DIELDRIN | 49 - 163 | steady state bioconcentration factor for liver, calculated on a wet weight basis; range for 7 doses | Not Reported | Juvenile | 8-16/dose | 0, 0.014, 0.019, 0.052, 0.075, 0.118, 0.177, 0.193 mg/L | TOX-EXP IND - accumulation | 8-34 d | waterborne | Toxicity Factor Datasets |
DIELDRIN | 5.5 - 95 | steady state bioconcentration factor for muscle, calculated on a wet weight basis; range for 7 doses | Not Reported | Juvenile | 8-16/dose | 0, 0.014, 0.019, 0.052, 0.075, 0.118, 0.177, 0.193 mg/L | TOX-EXP IND - accumulation | 8-34 d | waterborne | Toxicity Factor Datasets |
DIELDRIN | see citation | figures of tissue dieldrin concentrations at different exposure times and doses | Not Reported | Juvenile | 10/dose | 0, 0.3, 16, 48, 155, 272, 606 ug/g diet | TOX-EXP IND - accumulation | 24 d | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
DICOFOL | 5.4 (0.3 SE) ug/g wet wt. @ 3 ug/g diet; 18.1 (1.2 SE) @ 10 ug/g diet; 37.1 (1.6 SE) @ 30 ug/g diet; 150.7 (9.9SE) @ 100 ug/g diet, | mean egg yolk concentrations of p,p'-dicofol after 37-42 d on dicofol diet | Female | Adult | 4-8/dose | 0, 3, 10, 30, 100 ug/g diet | TOX-EXP IND - accumulation | 42 d | diet | Toxicity Factor Datasets |
DDE (4,4'-) | 10.3 (0.9 SE) ug/g wet wt. @ 3 ug/g diet; 91.5 (1.5 SE) @ 30 ug/g diet; 332.0 (26.0 SE) @ 100 ug/g diet | mean egg yolk concentrations after 37-42 d on DDE diet | Female | Adult | 5-10/dose | 0, 3, 30, 100 ug/g diet | TOX-EXP IND - accumulation | 42 d | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
DIELDRIN | 0.3 ug/g dry wt. @ 0 ppm; 0.9 - 5.0 @ 1 ppm; 4.1 - 40.1 @ 5ppm; 6.1 - 78.5 @ 10 ppm | dieldrin concentrations in egg dry matter ranging from 0-14 d to 330 - 343 d sampling periods at 4 dietary doses | Female | Adult | 18/dose | 0, 1, 5, 10 mg/kg diet | TOX-EXP IND - accumulation | 343 d | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Location | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|---|
DDT (Technical Grade Mixture) | see citation | table of DDE, DDD and DDT residues in 21 tissues following varying times after application | Not Reported | Not Reported | Sandusky Bay, Port Clinton | 1-6/sample | 0.2 lb/acre | TOX-EXP IND - accumulation | 0-413 d | field application | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Location | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|---|
RADIONUCLIDES | 131I 10d; 140Ba 22d; 51Cr 86d; 58Co 32d; 75Se 26d; 65Zn 67d; 134Cs 10d; 60Co 67d; 137Cs 11 d | mean biological half-lives for whole-body retention of 9 radionuclides; ducks exposed in field for varying time periods then depurated in laboratory to determine half-life | Both Male and Female | Not Reported | Idaho National Engineering Lab | 4-6/sample | see citation for figure of whole-body residues at time 0 | TOX-EXP IND - accumulation | 75 - 145 d | site contamination | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
ENDRIN | see citation | figures of carcass and blood endrin concentrations during elimination period (0-64d) | Male | Adult | 2-5/sample | 0, 20 mg/kg diet | TOX-EXP IND - accumulation | 13 d | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
DDE (4,4'-) | 0.021 - 0.028 ppm wet wt @ 0 ppm; 5.8 (0.32 SE; range 4.28-7.23) ppm wet wt @ 3 ppm | mean and range of DDE egg concentrations | Female | Adult | 8 eggs/dose | 0, 3 mg/kg diet | TOX-EXP IND - accumulation | 3-6 mo | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
LINDANE | serum (0.13); fat (0.20); muscle (0.70); kidney (0.02); liver (0.02); brain (0.01) ppm @ 20 mg/kg 2x/wk | mean lindane residue levels | Female | Adult | 5/dose | 20 mg/kg given 7x, 3x or 2x per wk | TOX-EXP IND - accumulation | 8 wks | gavage | Toxicity Factor Datasets |
LINDANE | serum (0.20); fat (0.68); muscle (0.30); kidney (0.23); liver (0.14); brain (0.11) ppm @ 20 mg/kg 3x/wk | mean lindane residue levels | Female | Adult | 5/dose | 20 mg/kg given 7x, 3x or 2x per wk | TOX-EXP IND - accumulation | 8 wks | gavage | Toxicity Factor Datasets |
LINDANE | serum (0.50); fat (1.14); muscle (0.82); kidney (0.28); liver (0.21); brain (0.13) ppm @ 20 mg/kg 7x/wk | mean lindane residue levels | Female | Adult | 5/dose | 20 mg/kg given 7x, 3x or 2x per wk | TOX-EXP IND - accumulation | 8 wks | gavage | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
DDE (4,4'-) | 373 (95% CL; 152-574) ppm lipid basis @ 40 ppm diet | DDE residue concentrations in eggs | Female | Adult | 12 | 0, 40 ppm DDE | TOX-EXP IND - accumulation | 8-94 d | diet | Toxicity Factor Datasets |
AROCLOR 1254, DDE (4,4'-) | 344 (95% CL; 156-686) ppm DDE lipid basis and 346 (95%CL; 133-686) ppm PCB lipid basis @ 40 ppm DDE + 40 ppm PCB diet | mean DDE and PCB residue levels in eggs | Female | Adult | 13 | 0, 40 ppm DDE + 40 ppm PCB | TOX-EXP IND - accumulation | 7-128 d | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
VANADYL SULFATE | increased @ 100 ppm (maximum = 106 +/- 19 ppb, wet wt) | vanadium concentration in blood (sampled at 3 wk intervals) | Both Male and Female | Adult | 5 pairs/group | 0, 1, 10, 100 ppm diet | TOX-EXP IND - accumulation | 12 wks | diet | Toxicity Factor Datasets |
VANADYL SULFATE | brain, 9(1); fat, 20(11); kidney, 273(49); liver, 657(113), male femur 274(47); female femur 3327(2208) ppm, wet wt | mean (SE) vanadium concentrations @ 100 ppm dose in brain, fat, kidney, liver, and femur | Both Male and Female | Adult | 5 pairs/group | 0, 1, 10, 100 ppm diet | TOX-EXP IND - accumulation | 12 wks | diet | Toxicity Factor Datasets |
VANADYL SULFATE | <0.02 ppb, wet wt @ 1, 10 ppm; 63 ppb, wet wt @ 100 ppm | vanadium concentration in eggs | Female | Adult | 5 pairs/group | 0, 1, 10, 100 ppm diet | TOX-EXP IND - accumulation | 12 wks | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
LEAD (elemental) | ppm wet wt: 3.47 (1.38), blood; 32.16 (11.60), liver; 114.78 (28.96), femur @ 2 #four shot | mean (2SE) lead concentration in liver, femur and blood | Male | Adult | 11 birds | 2 # four shot | TOX-EXP IND - accumulation | single | oral intubation | Toxicity Factor Datasets |
LEAD (elemental) | ppm wet wt: 4.15 (3.56), blood; 13.85 (7.96), liver; 577.07 (156.4), femur@ 2 #four shot | mean (2SE) lead concentrations in liver, femur and blood | Female | Adult | 5 birds | 2 # four shot | TOX-EXP IND - accumulation | single | oral intubation | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
LEAD (elemental) | increased @ 7, 14, 21 d post-dose | concentration of lead in blood versus controls | Male | Adult | 4/group | 0, 1 #four shot plus SRBC immune challenge at 0, 7, 14, 21 d post-dose | TOX-EXP IND - accumulation | single | oral intubation | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Location | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|---|
ENDRIN | breast muscle=non-detect.; liver=non-detect.-0.05; fat=non-detect.-0.50 ppm, wet wt | tissue endrin residues | Not Reported | Not Reported | Wenatchee | 7-10 animals | 1.3-1.7 kg/ha | TOX-EXP IND - accumulation | NR | pesticide application (late fall) | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
LEAD (elemental) | lead only: 112.27 (+/- 44.27); lead-iron: 32.65 (+/- 16.58) ppm, wet wt | lead concentration in bone (mean +/- SE) | Female | Adult | control=2 F, 4 M; treatment=6 M-F pairs/group | 0, 1 #four lead shot, or 1 #four iron-lead shot (47.5% lead) | TOX-EXP IND - accumulation | single | intubation | Toxicity Factor Datasets |
LEAD (elemental) | lead only: 10.22 (+/- 1.46); lead-iron: 3.38 (+/- 0.56) ppm, wet wt | lead concentration in bone (mean +/- SE) | Male | Adult | control=2 F, 4 M; treatment=6 M-F pairs/group | 0, 1 #four lead shot, or 1 #four iron-lead shot (47.5% lead) | TOX-EXP IND - accumulation | single | intubation | Toxicity Factor Datasets |
LEAD (elemental) | lead only: 0.71 (+/- 0.25); lead-iron: 0.31 (+/- 0.06) ppm, wet wt | lead concentration in blood (mean +/- SE) | Female | Adult | control=2 F, 4 M; treatment=6 M-F pairs/group | 0, 1 #four lead shot, or 1 #four iron-lead shot (47.5% lead) | TOX-EXP IND - accumulation | single | intubation | Toxicity Factor Datasets |
LEAD (elemental) | lead only: 0.49 (+/-0.10); lead-iron: 0.23 (+/- 0.04) ppm, wet wt | lead concentration in blood (mean +/- SE) | Male | Adult | control=2 F, 4 M; treatment=6 M-F pairs/group | 0, 1 #four lead shot, or 1 #four iron-lead shot (47.5% lead) | TOX-EXP IND - accumulation | single | intubation | Toxicity Factor Datasets |
LEAD (elemental) | lead only: 3.53 (+/- 1.43); lead-iron: 1.42 (+/- 0.65) ppm, wet wt | lead concentration in kidneys (mean +/- SE) | Female | Adult | control=2 F, 4 M; treatment=6 M-F pairs/group | 0, 1 #four lead shot, or 1 #four iron-lead shot (47.5% lead) | TOX-EXP IND - accumulation | single | intubation | Toxicity Factor Datasets |
LEAD (elemental) | lead only: 1.02 (+/- 0.22); lead-iron: 0.75 (+/- 0.10) ppm, wet wt | lead concentration in kidneys (mean +/- SE) | Male | Adult | control=2 F, 4 M; treatment=6 M-F pairs/group | 0, 1 #four lead shot, or 1 #four iron-lead shot (47.5% lead) | TOX-EXP IND - accumulation | single | intubation | Toxicity Factor Datasets |
LEAD (elemental) | lead only: 1.15 (+/- 0.29); lead-iron: 0.32 (+/- 0.05) ppm, wet wt | lead concentration in liver (mean +/- SE) | Female | Adult | control=2 F, 4 M; treatment=6 M-F pairs/group | 0, 1 #four lead shot, or 1 #four iron-lead shot (47.5% lead) | TOX-EXP IND - accumulation | single | intubation | Toxicity Factor Datasets |
LEAD (elemental) | lead only: 0.58 (+/- 0.19); lead-iron: 0.25 (+/- 0.02) ppm, wet wt | lead concentration in liver (mean +/- SE) | Male | Adult | control=2 F, 4 M; treatment=6 M-F pairs/group | 0, 1 #four lead shot, or 1 #four iron-lead shot (47.5% lead) | TOX-EXP IND - accumulation | single | intubation | Toxicity Factor Datasets |
LEAD (elemental) | increased with lead shot (egg contents: 0.50 +/-0.06; egg shell: 2.80 +/-0.25 ppm, wet wt) and lead-iron shot (egg shell: 1.42 +/-0.26 ppm, wet wt) | lead in egg contents and shell (mean +/- SE) versus controls | Female | Adult | control=10 eggs; treatment=20 eggs | 0, 1 #four lead shot, or 1 #four iron-lead shot (47.5% lead) | TOX-EXP IND - accumulation | single | intubation | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
LEAD NITRATE | increased @ 25 ppm/3wks | accumulation in livers and kidneys versus controls | Male | Adult | 20/dose; 5/dose x time group | 0, 1, 5, 25 ppm diet | TOX-EXP IND - accumulation | 3, 6, 9, or 12 wks | diet | Toxicity Factor Datasets |
LEAD NITRATE | increased @ 5 ppm diet (66 +/-13 ppm blood) and @ 25 ppm diet (154 +/-28 ppm blood) | lead concentration in blood after 12 weeks exposure (mean +/- SE) versus controls | Male | Adult | 20/dose; 5/dose x time group | 0, 1, 5, 25 ppm diet | TOX-EXP IND - accumulation | 3, 6, 9, or 12 wks | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
DDE (4,4'-) | 78.2 (carcass); 61.6 (egg); 4.1 (brain) ppm, wet wt | DDE residues in whole carcass, egg contents, and brain | Female | Adult | 10/group | 40 ppm DDE | TOX-EXP IND - accumulation | approx. 2 mos. | diet | Toxicity Factor Datasets |
MERCURY COMPOUNDS | 2.5 (carcass); 1.25 (egg); 23.7 (kidney) ppm, wet wt | mercury residues in whole carcass, egg contents, and kidneys | Female | Adult | 10/group | 200 ppm N-(ethylmercury)-p-toluene sulfoanilide | TOX-EXP IND - accumulation | 55 d | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|
SELENIUM COMPOUNDS | 36.11 - 88.4 ug/g wet wt (liver); 7.12 - 32.8 ug/g wet wt (kidney) | selenium concentration range in liver and kidney of dead animals | Not Reported | Not Reported | 3 | fish diet Se concn. range; 0.70 - 1.06 ug/g wet wt | TOX-EXP IND - accumulation | NR | diet | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Location | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|---|
CESIUM COMPOUNDS | 0.24 (0.027 SE) Bq/g, wet weight (whole body) 0.30 (0.036 SE) Bq/g, wet weight (muscle) | whole body and muscle concentrations of 137Cesium | Both Male and Female | Both Adults and Juveniles | Par Pond reservoir system, Savannah River Site | 27 doves | 0.56 (0.065 SE) Bq/g, wet wt, ingesta | TOX-EXP IND - accumulation | NR | diet (via site contamination) | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Location | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|---|
ENDRIN | breast muscle=0.02 ppm, wet wt | tissue endrin residues | Not Reported | Not Reported | Wenatchee | 1 animal | 1.3-1.7 kg/ha | TOX-EXP IND - accumulation | NR | pesticide application (late fall) | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Location | Sample Size | Tox Exposure | Toxicity Endpoint Type | Tox Exposure Duration | Tox Exposure Technique | Type |
---|---|---|---|---|---|---|---|---|---|---|---|
ENDRIN | brain=greater than or equal to 0.8 ppm, wet wt | tissue endrin residues | Not Reported | Not Reported | Wenatchee | 1-3 animals | 1.3-1.7 kg/ha | TOX-EXP IND - accumulation | NR | pesticide application (late fall) | Toxicity Factor Datasets |